Entrar/Registro  
HOME SPANISH
 
Gaceta Médica de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Gaceta Médica de México >Year 2010, Issue 6


Izazola LJA, Magis RC, Bravo GE, Ortiz MR, Rivera RP, García LC
Avance y retos de la prevención y el control del SIDA en México
Gac Med Mex 2010; 146 (6)

Language: Español
References: 55
Page: 411-422
PDF: 111.71 Kb.


Full text




ABSTRACT

This document aims to give an epidemiological overview of HIV and AIDS in Mexico, to highlight some aspects of both the governmental and nongovernmental response, and to emphasize important challenges in the fight against the epidemic.
The HIV and AIDS epidemic in Mexico is confined to specific groups such as men who have sex with men and intravenous drug users. It has low prevalence among general population, a percentage we aim to maintain.
Universal access to retroviral treatment in Mexico is an achievement that is sustainable only if a constant reduction of new cases is accomplished. This can only be obtained by preventive measures that are based on evidence. It is necessary to strengthen nongovernmental associations that are working on prevention. In 2009, the number of nongovernmental associations that received official financing was relatively low.
It is necessary to improve the epidemic vigilance and evaluation systems. This would allow better follow-up of the activities that confront the epidemic, and to obtain better feedback for the procedures.


Key words: AIDS, Prevention, Treatment, Mortality.


REFERENCIAS

  1. PNUD. Informe sobre el desarrollo humano. Nueva York: PNUD; 2005.

  2. Thurlow J, Gow J, George G. HIV/AIDS, growth and poverty in KwaZulu-Natal and South Africa: an integrated survey, demographic and economy-wide analysis. Journal of the International AIDS Society. 2009;12:18. doi:10.1186/1758-2652-12-18.

  3. Piot P, Greener R, Russell S. Squaring the circle: AIDS, poverty, and human development. PLoS Medicine. 2007;4:1571-5.

  4. ONU. Informe sobre los objetivos de desarrollo del milenio 2009. Nueva York: ONU; 2009.

  5. ONUSIDA. Situación de la epidemia de SIDA, diciembre de 2009. Suiza: ONUSIDA; 2009.

  6. Magis Rodríguez C, Bravo García E, Gayet Serrano C, Rivera Reyes P, De Luca M. El VIH y el SIDA en México al 2008. Hallazgos, tendencias y reflexiones. México: CENSIDA; 2008.

  7. Bayer R, Fairchild AL. New Englang Journal of Medecine. 2006; 335:647-9.

  8. WHO/UNAIS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO; 2007.

  9. SSA. Programa de acción específico 2007-2012. En respuesta al VIH/SIDA e ITS. México: SSA; 2008.

  10. Weinhardt LS, Carey MP, Johnson BT, Bickham NL, Effects of HIV Counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89: 1397-405.

  11. Marks G, Crepaz N, Senterfitt W, Janssen RS. Meta-analysis of high-risk sexual behaviour en persons aware and unaware they are infected with HIV in the United States. Implications for HIV programs. J Aqyuir Immune defic Syndrom. 2005;39:446-53.

  12. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-50.

  13. Bongaarts J, Pelletier F, Gerland P. Global trends in AIDS mortality. Population Counsil Inc. Estados Unidos. 2009.

  14. Arrivillaga M, Ross M, Useche B, Alzate ML, Correa D. Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Rev Panam Salud Pública. 2009;26:502-10.

  15. García-Sánchez I. Diferencias de género en el VIH. Gac Sanit. 2004; 18(Suppl 2):47-54.

  16. Harling G, Wood R, Beck EJ. Efficiency of Intervention in HIV Infection, 1994-2004. Disease Management and Health Outcomes. 2005; 13:371-94.

  17. Badri M, Maartens G, Mandalia S, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. Plos Medicine. 2006; 3;48-56.

  18. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146:87-95.

  19. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11-9.

  20. Beck E, Walensky RP. The outcome and impact of ten years of HAART. En: A Decade of HAART. Zuniga JM, et al. (Eds) Oxford: Oxford University Press; 2008.,

  21. ONUSIDA. Directrices prácticas del ONUSIDA para intensificar la prevención del VIH: Hacia el acceso universal. Ginebra: ONUSIDA; 2007.

  22. WHO/ONUSIDA/UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. Suiza: WHO; 2009.

  23. ONUSIDA. Informe sobre la epidemia mundial de SIDA 2006. Suiza: ONUSIDA; 2008.

  24. Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review. PLoS Med. 2007;4:1901-11.

  25. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA. 2007;298:2412-4.

  26. ONUSIDA. Informe sobre la epidemia mundial de SIDA 2008. Suiza: ONUSIDA; 2008.

  27. Gayet C, Magis C, Sacknoff D, Guli L. Prácticas sexuales de las poblaciones vulnerables a la epidemia de VIH/SIDA en México. CENSIDA/FLACSO-México. 2007.

  28. Moyer LB, Brouwer KC, Brodine SK, et al. Barriers and missed opportunities to HIV testing among injection drug users in two Mexico –US border cities. Drug and Alcohol Review. 2008;27:39-45.

  29. CENSIDA. Actividades de reducción del daño en usuarios de drogas. México: CENSIDA; 2008.

  30. WHO/ONUSIDA/UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. Suiza: WHO; 2009.

  31. Secretaria de Salud. Encuesta Nacional de Adicciones 2008. México: SSA; 2008.

  32. Reunión de ministros de salud y educación para detener el VIH en Latinoamérica y el Caribe. Declaración ministerial. Prevenir con educación. México: UNFPA-México; 2008.

  33. UNESCO. Un enfoque estratégico: El VIH y el SIDA y la educación. París: UNESCO; 2009.

  34. Hargreaves JR. Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub- Saharan Africa. AIDS. 2008;22:403-14.

  35. Johnson LF, Dorrington RE, Bradshaw D, Du Plessis H, Makubalo L. The effect of educational attainment and other factors on HIV risk in South African women: results from antenatal surveillance, 2000-2005. AIDS. 2009;23(12):1583-8.

  36. Hargreaves J, Boler T. Girl power: girls’ education, sexual behaviour and AIDS in Africa. Johannesburgo: ActionAid International; 2006.

  37. UNESCO. Educación para todos en el 2015. ¿Alcanzaremos la meta? Resumen. París: UNESCO; 2007.

  38. Biddlecom AE, Hessburg L, Singh S, Bankole A, Darabi L. Protecting the next generation in sub-Saharan Africa: learning from adolescents to prevent HIV and unintended pregnancy. Nueva York: Guttmacher Institute; 2007.

  39. Maulen-Destefani G, Silva BJ, Del Rio CC, Uribe ZP. Three years of mass media communication campaigns in Mexico. Int Conf AIDS. 1996 Jul 7-12;11:499 [abstract 1394].

  40. Bertrand JT, O’Reilly K, Denison J, Anhang R, Sweat M. Systematic review of the effectiveness of mass communication programs to change HIV/AIDS-related behaviors in developing countries. Health Education Research. 2006;21(4):567-97.

  41. Noar SM, Palmgreen P, Chabot M, Dobransky N, Zimmerman RS. A 10-year systematic review of HIV/AIDS mass communication campaigns: Have we made progress?. Journal of Health Communication. 2009;14:15-42.

  42. Marston M, Todd J, Glynn JR, et al. Estimating ‘net’ HIV-related mortality and the importance of background mortality rates. AIDS. 2007;(Suppl. 6):S65-71.

  43. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middleincome countries before highly active antiretroviral therapy. AIDS. 2007;21(Suppl 6):S55-63.

  44. Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of Treatment: updates to the Spectrum projection package. Sexually Transmitted Infections. 2006:82(Suppl 3):45-50.

  45. ONUSIDA. Situación de la epidemia de SIDA: informe especial sobre la prevención del VIH: Diciembre de 2007. Suiza: ONUSIDA; 2007.

  46. Kaai S. Changes in stigma among a cohort of people on antiretroviral therapy: findings from MombasaKenya. Nairobi. Research summary. Estados Unidos: The Population Council Inc.; 2007.

  47. SSA. Guía de manejo antirretroviral de las personas con VIH. México: SSA; 2008.

  48. Heywood MJ. Litigating AIDS: background, strategies and outcomes of the treatment action campaign’s (TAC) case to prevent mother to child HIV transmission in South Africa. Decimocuarta Conferencia Internacional sobre el SIDA, 7-12 de julio. Ginebra: Sociedad Internacional del SIDA; 2002.

  49. Jones P. A Test of Governance: rights-based struggles and the politics of HIV/AIDS policy in South Africa. Political Geography. 2005;24:419-47.

  50. Harling G, Wood R, Beck EJ. Efficiency of Intervention in HIV Infection, 1994-2004. Disease Management and Health Outcomes. 2005; 13:371-94.

  51. Badri M, Maartens G, Mandalia S, et al. Cost-ffectiveness of highly active antiretroviral therapy in South Africa. Plos Medicine. 2006;3:48-56.

  52. Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Med. 2007;4:1804-17.

  53. ONUSIDA. Financing resources required to achieve universal access to HIV prevention, treatment, care and support. Ginebra: ONUSIDA; 2007.

  54. Hecht R, Bollinger L, Stover J, et al. Critical choices in financing the response to the global HIV/AIDS pandemic. Health Affairs. 2009;28:1591-605.

  55. Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE. The spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect. 2008;84:i24-30.






>Journals >Gaceta Médica de México >Year 2010, Issue 6
 

· Journal Index 
· Links 






       
Copyright 2019